IMUX
Immunic, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsLast reportshaded = implied▲▼ = realized× = |realized| ÷ implied
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Standard Life AberdeenStandard Life Aberdeen | $12.7M | 9.46% | −90.00% | |
| 2 | BVFBVF | $11.8M | 8.78% | −90.00% | |
| 3 | Millennium ManagementMillennium | $11.4M | 8.49% | −80.41% | |
| 4 | Avidity Partners ManagementAvidity Partners | $10.3M | 7.68% | −90.91% | |
| 5 | BraidwellBraidwell | $9.9M | 7.40% | new | |
| 6 | Laurion Capital ManagementLaurion | $9.4M | 7.00% | −84.28% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $8.8M | 6.56% | −88.88% | |
| 8 | Jones Hill CapitalJones Hill Capital | $8.3M | 6.19% | new | |
| 9 | Woodline PartnersWoodline Partners | $7.2M | 5.41% | −51.25% | |
| 10 | Soleus Capital ManagementSoleus | $6.9M | 5.16% | −90.00% | |
| 11 | Propel Bio ManagementPropel Bio | $5.0M | 3.73% | −86.14% | |
| 12 | Susquehanna International GroupSusquehanna International | $4.0M | 2.98% | −76.47% | |
| 13 | Nantahala Capital ManagementNantahala | $3.9M | 2.87% | −90.00% | |
| 14 | UBS GroupUBS | $2.7M | 2.02% | −66.38% | |
| 15 | Geode Capital ManagementGeodeindex-like | $2.6M | 1.96% | −88.81% | |
| 16 | 683 Capital Management683 Capital Management | $2.3M | 1.69% | −93.99% | |
| 17 | Adage Capital Partners GPAdage Capital Partners GP | $2.1M | 1.60% | −90.00% | |
| 18 | BlackRockBlackRockindex-like | $2.0M | 1.52% | −86.23% | |
| 19 | Jane Street GroupJane Street | $1.6M | 1.20% | −86.99% | |
| 20 | Marshall WaceMarshall Wace | $1.6M | 1.20% | −89.00% | |
| 21 | Leucadia NationalLeucadia National | $1.3M | 0.97% | new | |
| 22 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.3M | 0.94% | −88.92% | |
| 23 | Ikarian CapitalIkarian Capital | $1.0M | 0.77% | −90.00% | |
| 24 | State StreetState Streetindex-like | $941,551 | 0.70% | −89.17% | |
| 25 | Quadrature CapitalQuadrature Capital | $580,771 | 0.43% | +27.54% |
No thesis.
Immunic, Inc.
7.53
57 managers report $134.0M of Immunic on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; Standard Life Aberdeen is largest at 9.46%.
Expected move
Inputsspot 7.51exp Nov 20ATM strike 7.5ATM straddle 2.47IV 174%